BGNE Articles, BeiGene Ltd.
home / stock / bgne / bgne articles
-
Over the past twenty days of trading, BeiGene Ltd. (NASDAQ: BGNE), from September 20, 2019 to October 17, 2019 there is a potential Short Squeeze a...
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
BeiGene 's (NASDAQ: BGNE) shares were up by more than 13% on Tuesday at 2:50 p.m. ET thanks to a regulatory body in China accepting one of the company's supplemental biologics licensing application filings for a new indication for its drug tislelizumab. The Center for Drug Evalu...
-
Submission seeks marketing authorization for use with chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma whose tumor expresses PD-L1 BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-dr...
-
BeiGene and NewBridge Pharmaceuticals To Bring BRUKINSA to Patients in MENA Region, Following Approval for Previously Treated Mantle Cell Lymphoma in Kuwait, Bahrain and Qatar BRUKINSA has Previously Been Approved by Regulatory Authorities in the U.S., China, the European Unio...